Stocks
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -3.15 | -2.21 | -1.39 | -2.45 | -1.68 | -2.03 | ||
| Changes by years, y/y, % | -58% | -30% | -37% | +77% | -31% | -25.7% | |||
Agios Pharmaceuticals. EV/EBITDA
Agios Pharmaceuticals. EV/EBITDA, changes, %
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -1.94 | -2.27 | -3.03 | -1.66 | -2.74 | -2.03 | |
| Changes by years, y/y, % | -35% | -53% | -23% | -33% | +41% | |||
| Changes by quarters, q/q, % | -22% | +17% | +33% | -45% | +65% | |||
